None listed
Conditions
Brief summary
This study is investigating the effect of an exercise program (pulmonary rehabilitation) delivered through videoconferencing for people who have been diagnosed with Long COVID-19 (ongoing symptoms 4 months or more after original COVID-19 infection.) People will be recruited to this study only if they are already enrolled in the ADAPT COVID-19 study running through St Vincent's Hospital Sydney (ACTRN12620000554965) Of those in the ADAPT study, people that have ongoing symptoms such as fatigue or breathlessness after four months will be offered the study. Study details Eligible participants will complete an initial assessment of one hours duration consisting of walking tests and questionnaires. After this appointment they will be randomly allocated to participate in either the exercise group or control group. The exercise group will complete two exercise sessions/week for eight weeks over Zoom supervised by a physiotherapist. Both groups will then complete the walking tests and questionnaires again after eight weeks. It is hoped that this study will provide further information about the role of pulmonary rehabilitation after COVID-19 in those with persistent symptoms.
Interventions
Intervention group will complete a twice/weekly rehabilitation program for eight weeks. This will be physiotherapist led and delivered through videoconferencing technology in groups of 4-6 participants. Exercise sessions will run for about an hour each and cover aerobic exercise (walking) and strengthening (such as sit to stand exercises) in a similar format to usual pulmonary rehabilitation. Participant's will exercise at a moderate level of exertion (either breathlessness or fatigue depending on participant's individual symptoms) and this will be monitored using 0-10 Borg dyspnoea and rate of perceived exertion scales. Adherence to the intervention will be recorded by the physiotherapist during each session on an exercise log which will track the number of sessions attended, exercises completed and any relevant issues during the sessions such as technological limitations or changes in participant symptoms.
Sponsors
Study design
Eligibility
Inclusion criteria
• Adult patients (>16 years) consented to the ADAPT cohort study with laboratory confirmed SARS-CoV-2 PCR positive (ACTRN12620000554965) • Long COVID-19 symptoms; defined as persistent symptoms of dyspnoea, chest pain or fatigue at follow up visit 4
Exclusion criteria
o Patients that are unwilling or unable to participate in the supervised telerehabilitation program o Those that have participated in a structured, supervised exercise program of at least 6 weeks in duration in the last 3 months (prior to enrollment in the Long COVID-19 rehabilitation study) o People with other comorbid conditions that would prohibit participation in exercise training such as unstable cardiovascular disease o People with pre-existing chronic lung disease (including COPD, bronchiectasis, interstitial lung disease) or chronic heart failure known to be amenable to pulmonary rehabilitation. This people will instead be referred to their local pulmonary or heart failure rehabilitation service o People who have an immediate family or household member already enrolled in this trial to limit potential contamination of groups. If this is the case, the person will be offered the opportunity to participate in the exercise program at a later date, if desired, but their data will not be included in the analysis.